IMV Technologies

through its NIFA Technologies subsidiary (part of the group since 2010, originally founded in 1948), is a world leader in semen packaging, cryopreservation and Computer Assisted Semen Analysis (CASA) equipment, supplying laboratories worldwide.

Country
France
lab-equipment eu
Coverage
CNEUUS
livestock-aqua
Regulatorsusda-aphisefsanmpa

Verifiable facts

FactValueSource
Funding4 prior funding rounds, totaling $114.21M (as of 2021)imv-technologies.com
CapacitySix manufacturing facilities across five continentsqualium-investissement.com · imv-technologies.com
CertificationISO 9001 and ISO 13485 compliant; NIFA Technologies holds ISO certificate since 1997frontier-intl.co.jp · imv-technologies.com.br · imv-technologies.com · imv-technologies.in · imv-technologies.us · nifa.nl
Regulatory approvalFDA 510(k) premarket notification clearances; CE marked; CSS-approved semen extenders medium confidencefrontier-intl.co.jp · naab-css.org
Production siteSeven production sites located in 5 countries (France, UK, Spain, Netherlands, China)qualium-investissement.com · imv-technologies.com
HeadcountOver 650 employees globally (as of 2025)qualium-investissement.com · imv-technologies.com
Revenue€135M (as of 2021)imv-technologies.com

Independent sources: frontier-intl.co.jp · naab-css.org · nifa.nl · qualium-investissement.com

Technologies
NameClusterRisk
Sperm-sexing & reproductive biotech in livestocklivestock-aquaMedium

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.